Panagiotis Kanellopoulos

22PUBLICATIONS
29CO-AUTHORS
Satellite-based positioningMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 17, 2026
Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging.

Karim Obeid, Ekaterina Bezverkhniaia, Vladimir Tolmachev

|Jan 15, 2026
Preclinical Evaluation of a 177Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus.

Naveen Kumar, Adrianna Bilinska, Elena Menéndez

|Nov 13, 2025
Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Karim Obeid, Ekaterina Bezverkhniaia, Vladimir Tolmachev

|Oct 29, 2025
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

Anna Orlova, Anastasia Rybina, Anna Medvedeva

|Oct 16, 2025
Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium-99m.

Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström

|Aug 28, 2025
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8.

Olga Bragina, Vladimir Chernov, Mariia Larkina

Pageof 4

Frequent Collaborators

12 joint publications

Berthold A Nock

12 joint publications

Theodosia Maina

9 joint publications

Anna Orlova

6 joint publications

Vladimir Tolmachev